Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Air Water Ventures LtdWATR · Entity 7070 | Director | August 14, 2026 | August 14, 2026 |
| Franklin BSP Real Estate Debt, Inc.NONE · Entity 81594 | Director | March 17, 2025 | March 25, 2025 |
| Franklin BSP Realty Trust, Inc.FBRT · Entity 5230 | Director | June 08, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Air Water Ventures Ltd
Report date August 14, 2026 · Filed August 14, 2026
This filing explicitly reported no securities owned.
Franklin BSP Real Estate Debt, Inc.
Report date March 17, 2025 · Filed March 25, 2025
This filing explicitly reported no securities owned.
Franklin BSP Realty Trust, Inc.
Report date June 08, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,761 |
Reported balance
After 2026-06-08 transaction · row 1
1 source rowRow 1 · 2026-06-08 · Grant · Acquired 12,835 · Balance 58,761 F1: Restricted shares of common stock issued pursuant to the issuer's 2021 Equity Incentive Plan. Restricted shares vest on the earlier of (i) the date of the issuer's 2027 Annual Meeting of Stockholders and (ii) June 8, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares of common stock issued pursuant to the issuer's 2021 Equity Incentive Plan. Restricted shares vest on the earlier of (i) the date of the issuer's 2027 Annual Meeting of Stockholders and (ii) June 8, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Endovia Health Sciences, Inc.
Report date April 24, 2023 · Filed May 15, 2023
Section 16 reporting ended · disclosed 2023-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.12 · Expires 2033-04-05 | Direct | 125,000 |
Reported balance
After 2023-04-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-04-24 · Grant · Acquired 125,000 · Balance 125,000 F1: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2026 Filed Jun 11, 2026 00:33 UTC | Franklin BSP Realty Trust, Inc. FBRT · Entity 5230 | GrantCommon Stock | 12,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-072488 · tm2617196-3_4seq1.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,761 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's 2021 Equity Incentive Plan. Restricted shares vest on the earlier of (i) the date of the issuer's 2027 Annual Meeting of Stockholders and (ii) June 8, 2027. Read SEC document |
| November 21, 2025 Filed Nov 22, 2025 00:07 UTC | Franklin BSP Realty Trust, Inc. FBRT · Entity 5230 | SaleCommon Stock | 1,500 | $10.00 | $14,995.50 |
DisclosureSEC source: 0001123292-25-000670 · form4.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,926 Read SEC document |
| May 28, 2025 Filed Jun 3, 2025 00:37 UTC | Franklin BSP Realty Trust, Inc. FBRT · Entity 5230 | GrantCommon Stock | 10,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-055628 · tm2516975-4_4seq1.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,426 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's 2021 Equity Incentive Plan. Restricted shares vest on the earlier of (i) the date of the issuer's 2026 Annual Meeting of Stockholders and (ii) May 28, 2026. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:33 UTC | Franklin BSP Realty Trust, Inc. FBRT · Entity 5230 | GrantCommon Stock | 2,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-087837 · tm2421202-4_4.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,390 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's 2021 Equity Incentive Plan. Restricted shares vest on the earlier of (i) the date of the issuer's 2025 Annual Meeting of Stockholders and (ii) August 7, 2025. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:23 UTC | Franklin BSP Realty Trust, Inc. FBRT · Entity 5230 | GrantCommon Stock | 6,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-067201 · tm2415856-4_4seq1.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,365 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's 2021 Equity Incentive Plan. Restricted shares vest on the earlier of (i) the date of the issuer's 2025 Annual Meeting of Stockholders and (ii) May 29, 2025. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:21 UTC | Franklin BSP Realty Trust, Inc. FBRT · Entity 5230 | GrantCommon Stock | 6,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-067572 · tm2317518d5_4.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,549 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's 2021 Equity Incentive Plan. Restricted shares vest on the earlier of (i) the date of the issuer's 2024 Annual Meeting of Stockholders and (ii) May 31, 2024. Read SEC document |
| April 24, 2023 Filed May 15, 2023 20:31 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantStock options · Derivative | 125,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001731122-23-000936 · ownership.xml · derivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common stock · 125,000 shares Expires 2033-04-05 F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 20:34 UTC | Franklin BSP Realty Trust, Inc. FBRT · Entity 5230 | GrantCommon Stock | 3,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-076877 · tm2220224-4_4seq1.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,341 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's Restricted Share Plan. Restricted shares vest on the earlier of (i) the date of the issuer's 2023 Annual Meeting of Stockholders and (ii) June 29, 2023. Read SEC document |
| September 30, 2021 Filed Apr 1, 2022 01:37 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantOption (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001731122-22-000651 · ownership.xml · derivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2026-09-30 F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 21:17 UTC | Franklin BSP Realty Trust, Inc. NONE · Entity 5230 | GrantCommon Stock | 2,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-077155 · tm2118809-3_4seq1.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,586 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's Restricted Share Plan. Restricted shares vest on the first anniversary of the grant date. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:32 UTC | Endovia Health Sciences, Inc. SBEV] · Entity 8508 | GrantWarrants (Right to Buy) · Derivative | 333,333 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001061 · ownership.xml · derivative · entry 3 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,333 Underlying: Common Stock · 333,333 shares Expires 2027-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:32 UTC | Endovia Health Sciences, Inc. SBEV] · Entity 8508 | GrantWarrants (Right to Buy) · Derivative | 333,333 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001061 · ownership.xml · derivative · entry 2 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,333 Underlying: Common Stock · 333,333 shares Expires 2026-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:32 UTC | Endovia Health Sciences, Inc. SBEV] · Entity 8508 | GrantWarrants (Right to Buy) · Derivative | 333,334 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001061 · ownership.xml · derivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,334 Underlying: Common Stock · 333,334 shares Expires 2025-10-15 F1 · price: Not applicable Read SEC document |
| May 28, 2020 Filed May 29, 2020 20:31 UTC | Franklin BSP Realty Trust, Inc. NONE · Entity 5230 | GrantCommon Stock | 2,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-067801 · tm2021301d2_4.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,251 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's Restricted Share Plan. Restricted shares vest on the first anniversary of the grant date. Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 20:00 UTC | Franklin BSP Realty Trust, Inc. NONE · Entity 5230 | PurchaseCommon Stock | 5,984 | $16.71 | $99,992.64 |
DisclosureSEC source: 0001144204-19-033366 · tv524474_4.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,844 Read SEC document |
| May 30, 2019 Filed May 31, 2019 20:01 UTC | Franklin BSP Realty Trust, Inc. NONE · Entity 5230 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-029216 · tv522647_4.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,860 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's Restricted Share Plan. Restricted shares vest on the first anniversary of the grant date. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:25 UTC | Franklin BSP Realty Trust, Inc. NONE · Entity 5230 | GrantCommon Stock | 1,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-032661 · tv495647_form4.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,260 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's Restricted Share Plan. Restricted shares vest on the first anniversary of the grant date. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 21:22 UTC | Franklin BSP Realty Trust, Inc. NONE · Entity 5230 | GrantCommon Stock | 1,496 | $20.05 | $29,994.80 |
DisclosureSEC source: 0001144204-17-030886 · v468296_4.xml · nonDerivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,683 F1 · shares: Restricted shares of common stock issued pursuant to the issuer's Restricted Share Plan. Restricted shares vest on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.